Home
2021/22 Media Kit
Continued Medical Education
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
National Advertising
Agenda
Directory
Join Today
Event Agenda
Video
Careers
Search
About
Advertise
Advisory Board
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Onco'Zine
Advertisement #1
Home
2021/22 Media Kit
Continued Medical Education
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
National Advertising
Agenda
Directory
Join Today
Event Agenda
Video
Careers
Home
Clinical development
Phase I
Page 3
Phase I
Phase I
Biomarkers Predict Better Immunotherapy Treatment Outcomes for Patients with Pancreatic Cancer
Danielle Garcia
-
June 6, 2022
Encouraging Results for Cabozantinib Mono- and Combination Therapy Across Different Tumor Types
Promising Activity with Zanidatamab In First-line Setting Of HER2+ Breast + Gastroesophageal Cancer
SORAYA Shows Consistent Safety Profile for Mirvetuximab Soravtansine in Ovarian Cancer
What to Expect at AACR: Long-term Outcomes for Sotorasib in KRAS G12C-mutated NSCLC
First Patient Dosed in Phase III Trial Evaluating AVB-500 in Platinum...
Peter Hofland, Ph.D
-
April 27, 2021
Combination of SLC-391 + Pembrolizumab Enters Clinical Trial Advanced NSCLC
Peter Hofland, Ph.D
-
March 31, 2021
Phase I Study Shows Positive Interim Results of TRPH-222 in Patients...
Peter Hofland, Ph.D
-
December 7, 2020
NIH Starts Clinical Trial with ONC206, a Next-Generation Imipridone
Editorial Team
-
October 29, 2020
Investigator-Initiated Study Supports Potential of VS-6766 as Treatment for RAS Mutant...
Editorial Team
-
October 29, 2020
Inhibition of HDAC + mTOR May Improve Outcomes in Relapsed/Refractory Hodgkin...
Editorial Team
-
October 14, 2020
ESMO 2020: First-in-class MK-4830 Antibody Targeting ILT4 Shows Promising Preliminary...
Editorial Team
-
September 20, 2020
ESMO 2020: Sotorasib Active in Patients with KRAS p.G12C Mutation –...
Editorial Team
-
September 20, 2020
1
2
3
Page 3 of 3
LATEST NEWS
Soft-Tissue Sarcomas Changes the Biology of Immune Cells Surrounding Tumors to Promote Tumor Growth
Editorial Team
-
June 22, 2022
Activating the Immune Response Enables Liver Cancer Patient’s Immune System to Kill Cancerous Cells
Editorial Team
-
June 21, 2022
Statue of a Woman with Incurable Breast Cancer Unveiled in Front of the Norwegian...
Editorial Team
-
June 20, 2022
Preventive Care May Be Free, but Follow-Up Diagnostic Tests Can Bring Big Bills
Michelle Andrews
-
June 14, 2022
Pioneering Novel Targeted Treatments in Lung Cancer
Editorial Team
-
June 10, 2022
X